Will Aurelia Song abandon Nectome before 2041?
One-OffGesundheit & MedizinWirtschaft & Unternehmen14J
Manifold MarketsKein KYCVerifizierte AuflösungsdatenGut kalibriertAktuelle Community-PrognoseNein 91.3%
Prognostiker
1
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 21 Stunden
Veraltet15. Apr. 26, 04:10 UTC31. Dez. 40, 23:59 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
Medtronic cardiovascular growth in Q2
KalshiWill 3 mg THC beverages be federally legal to sell?
KalshiWhen will Compass Pathways submit a NDA for COMP360 psilocybin?
KalshiWhich fast food chain in the USA will offer a lab-grown / cultivated meat product first?
Manifold MarketsWill an AI Labor Shock Crash Markets by 2035?
Manifold MarketsWhen will I be able to buy cultured meat at a random Whole Foods?
Manifold MarketsRegeln
Nectome is a brain preservation startup, founded by Aurelia Song circa 2015.
- This market resolves YES iff, before 2041, Aurelia Song leaves the company for any reasons other than:
- Health issues that prevent her from working a full-time job
- Being unilaterally pushed out by other stakeholders
- Aldehyde-stabilization is clearly demonstrated to not work and/or not be necessary (eg because of a positive singularity)
- If Nectome ceases to exist for mundane reasons, I will consider it abandonment if she doesn't act to try and do what's best for any people they really preserved, or if she decides to change careers in the aftermath.
